SkinEvidence check
Spironolactone for Acne: Four Checks on the SAFA Trial
The 12-week primary result and 24-week improvement reports answer different questions.
Free shipping
The library
SkinEvidence check
The 12-week primary result and 24-week improvement reports answer different questions.
Bloating & DigestionComparison
A Swedish comparison found similar four-week response rates. Its noninferiority margin, participant selection and follow-up limit what that means.
Sleep & NighttimeExplainer
A small older-adult trial found that assessment timing mattered. Its individual morning and later-day estimates remained uncertain.
SkinEvidence check
A 24-week split-face study measured sunken scars alongside active acne.
Bladder & Pelvic FloorEvidence check
Compare satisfaction, repeat procedures and complications when discussing treatment for stress leaks.
Odor & SweatQ&A
A small comparison measured comfort alongside sweat reduction and duration.
Intimate HealthEvidence check
Two small placebo trials found no clear benefit. Combination studies leave questions, and vaginal dosing can still put diazepam into the bloodstream.
Menopause & HormonesComparison
VEMORA adds symptom evidence for breast-cancer survivors. Recurrence risk remains a separate treatment question.
Intimate HealthEvidence check
Short-term symptom improvement, sham comparisons and the ongoing treatment plan.
PeriodsEvidence check
What a factor-infusion comparison adds to a specialist conversation about persistent menstrual bleeding.
The prevention trial's clinician-defined and symptom outcomes answer different questions.
HairEvidence check
A seven-month trial found improved brow fullness. Its dosing comparisons, a smaller gel study and the current eyelash label need separate interpretation.